Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cell Care Therapeutics

Cell Care Therapeutics?uq=w9if130k
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$1.58M LATEST DEAL AMOUNT
Description

Developer of mesenchymal stem cell derived bio-pharmaceuticals. The company develops mesenchymal stem cell derived bio-pharmaceuticals to treat inflammatory and degenerative ophthalmic diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 805 South Shamrock
  • Monrovia, CA 91016
  • United States

+1 (562) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cell Care Therapeutics’s full profile, request a free trial.

Cell Care Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Convertible Debt 28-Apr-2017 $1.58M 00.000 Completed Pre-Clinical Trials
1. Convertible Debt 31-Aug-2015 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cell Care Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Nicolas Sohl Co-Founder, Chief Executive Officer and Board Member
Rajashekhar Gangaraju Ph.D Co-Founder
David McQuillan Ph.D Advisor
Veronique Jotterand MD Co-Founder, Chief Medical Officer & Board Member

Cell Care Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Veronique Jotterand MD Cell Care Therapeutics Co-Founder, Chief Medical Officer & Board Member 000 0000